Lundbeck to measure brain with microscopic camera in new partnership
In a research collaboration with the US-based Inscopix, Lundbeck hopes to find some answers to the question of why it's so difficult to develop drugs against psychiatric disorders.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL PEDERSEN
The US Food & Drug Administration's recent approval of Biogen's Alzheimer drug, Aduhelm, has sparked debate and controversy over how to measure the efficacy of medications against psychiatric and neurological disorders.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
